Skip to content

All Lessons

Introduction to FDA’s Office of Trade and Global Partnerships (OTGP)

Introduction to Water Systems (FDA Compounding Conference 2025)

Investigator Responsibilities – Regulation and FDA Expectations for the Conduct of Clinical Trials

Key Information in Informed Consent (Clinical Trials) 

Keynote (Advancing Generic Drug Development 2024)

Keynote (Electronic Drug Registration and Listing 2024)

Landscape of Stakeholder Perspectives: Future Needs for the Development of Interchangeable Products

Laser Diffraction (LD) Theory and Practice (Particle Size Analysis)

Listing Your Drug Using CDER Direct

Mastering Controlled Correspondences: What, When, and How

Media Fills (FDA Compounding Conference 2025)

Medical Device Reporting: Viewing Adverse Events as Opportunities for Transformation

Meeting Patient Needs for the Future (FDA Compounding Conference 2025)

Meeting Patient Needs Through the Years (FDA Compounding Conference 2025)

Meeting the Needs of Special Populations (FDA Compounding Conference 2025)

Minor Regulatory Errors with Major Consequences

Model Master Files: How to Develop and Submit One? 

Modeling and AI in Generic Drug Development 2025: AI and Quantitative Medicine – Presentations

Modeling and AI in Generic Drug Development 2025: AI and Quantitative Medicine – Q&A Panel

Modeling and AI in Generic Drug Development 2025: AI Streamlining Workflows – Presentations

Modeling and AI in Generic Drug Development 2025: AI Streamlining Workflows – Q&A Panel

Modeling and AI in Generic Drug Development 2025: AI Supporting Drug Development – Presentations

Modeling and AI in Generic Drug Development 2025: AI Supporting Drug Development – Q&A Panel

Modeling and AI in Generic Drug Development 2025: Regulatory Perspectives and Opportunities – Presentations

Modeling and AI in Generic Drug Development 2025: Regulatory Perspectives and Opportunities – Q&A Panel

1 … 7 8 9 10 11 … 16
Share: